Image

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

Study on Alpha DaRT224 for recurrent skin cancer treatment.

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study looks at a new treatment called **Alpha DaRT-224** for people with a type of skin cancer known as **recurrent cutaneous squamous cell carcinoma (SCC)**. The treatment involves placing a special radioactive source directly into the tumor, which releases radiation to kill cancer cells. This study aims to see how effective and safe this treatment is for up to 86 participants. DaRT seeds stay in the tumor for 14-21 days.

Participants will be monitored for 6 months to see how well they respond to the treatment and how long the response lasts. The study will also check for any side effects from the treatment. To join, participants must have certain health conditions and meet specific requirements like tumor size and life expectancy.

  • Duration: Monitored for up to 6 months after treatment.
  • Visits: Regular check-ups to monitor response and side effects.
  • Eligibility: Must have recurrent SCC and be unable to have surgery or standard radiation.
Print
Study details
    Recurrent Squamous Cell Carcinoma

NCT05323253

Alpha Tau Medical LTD.

30 March 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.